Trade AKTX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Akari Therapeutics plc ADS (AKTX) is trading at US$9.33, up 3.55% today as of Aug 28, 12:57 EDT. The company has a market capitalisation of US$15.28M. Over the past 52 weeks, AKTX has traded between US$3.02 and US$49.60. On Syfe you can trade AKTX with $0 commission and add it to your watchlist.
| Previous close | US$9.01 |
|---|---|
| Market cap | US$15.28M |
| 52-week range | US$3.02 – US$49.60 |
| Volume | 53.88K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Akari Therapeutics plc ADS
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
Year: 2012
Akari Therapeutics, Whitehawk Therapeutics Collaborate to Develop ADC Cancer Treatments
Jul 21, 12:24 PM · MT Newswires
Top Premarket Decliners
May 26, 11:37 AM · MT Newswires
Top Midday Gainers
May 22, 5:18 PM · MT Newswires
Akari Therapeutics Announces Ratio Change for American Depositary Shares
Mar 17, 9:51 PM · MT Newswires
Akari Therapeutics plc ADS (AKTX) stock is trading at US$9.33, +3.55% from the previous close of US$9.01.
The market cap for Akari Therapeutics plc ADS (AKTX) stock is approximately US$15.28M.
The 52-week high for Akari Therapeutics plc ADS (AKTX) stock is US$49.60.
The 52-week low for Akari Therapeutics plc ADS (AKTX) stock is US$3.02.
Akari Therapeutics plc ADS (AKTX) does not currently pay a dividend.
Stay on top of AKTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
